Cessation versus Continuation of Galantamine Treatment after 12 Months of Therapy in Patients with Alzheimer's Disease: A Randomized, Double Blind, Placebo Controlled Withdrawal Trial / E. Scarpini, G. Bruno, G. Zappalà, M. Adami, U. Richarz, M. Gaudig, A. Jacobs, B. Schäuble. - In: JOURNAL OF ALZHEIMER'S DISEASE. - ISSN 1387-2877. - (2011).
Cessation versus Continuation of Galantamine Treatment after 12 Months of Therapy in Patients with Alzheimer's Disease: A Randomized, Double Blind, Placebo Controlled Withdrawal Trial
E. ScarpiniPrimo
;
2011
File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
Scarpini et al., JAD.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
146.99 kB
Formato
Adobe PDF
|
146.99 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.